HPV self-collection program for cervical cancer screening

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program aims to develop and implement HPV self-collection protocols for women overdue for cervical cancer screening. It includes both in-clinic and home-based options for self-collection, allowing women to choose how they want to participate in screening. The initiative will also provide educational resources to inform participants about HPV and cervical cancer, as well as instructions on using the self-collection kits. The goal is to improve screening rates and follow-up care for HPV-positive results in community health settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women and individuals with a cervix.
* Aged 25-65 years during the study measurement period.
* Qualifying visit to the participating clinic.
* Overdue for cervical cancer screening.
* Those aged 24-64 who have not had cervical cytology (i.e., Pap test) performed within the last three and a half (3.5) years, or those aged 30-65 who have not had cervical HPV testing (i.e., primary HPV testing or contesting for HPV with Pap test) performed within the last five and a half (5.5) years.

Exclusion Criteria:

* Individuals without a cervix.
* Receiving hospice and/or palliative care during any part of the measurement period.

Where it's running

• University of Utah Health Hospitals/Huntsman Cancer Institute Population Sciences
  Salt Lake City, Utah, United States Recruiting

Study contacts

• Principal investigator: Deanna Kepka, PhD, MPH — University of Utah
• Study coordinator: Deanna Kepka
• Email: Deanna.Kepka@hci.utah.edu
• Phone: 801-587-4565

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Can people collect their own vaginal sample for HPV testing as well as clinician collection for comparison?

  This study tests whether individuals can correctly use a self-collection device to gather a vaginal sample for high-risk HPV screening and whether the self-collected sample agrees with clinician-collected samples.

  Recruiting at 11 sites Mel Mont Medical · Phoenix, Arizona and 10 other locations · NCT07758140

• Two-probe thermal ablation for cervical precancer in WLWH in South Africa

  This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in South Africa.

  Recruiting Fred Hutchinson Cancer Center · Durban · NCT07645378

• Two-probe thermal ablation for cervical precancer in WLWH in Zimbabwe

  This study tests whether using two TA probes (endocervical and ectocervical) is better than one probe for treating cervical precancer in women living with HIV in Zimbabwe.

  Recruiting Fred Hutchinson Cancer Center · Harare · NCT07645352

• Digital tools to boost HPV vaccination intentions among Nigerian caregivers

  This study tests whether different online content can help Nigerian parents of unvaccinated girls ages 9-14 decide to vaccinate their daughters against HPV.

  Recruiting University of Pennsylvania · Lagos · NCT07498075

• HPV monitoring after chemoradiotherapy for cervical cancer

  This project will test whether HPV detected on cervical swabs and in blood can find cancer recurrence in people with stage IB–IVA cervical cancer after curative chemoradiotherapy.

  Recruiting General University Hospital, Prague · Prague · NCT07493928

• Two-probe thermal ablation for cervical precancer in HIV+ women in Kenya

  This study tests whether using two probes for thermal ablation is more effective and acceptable than one probe for treating cervical precancer in women living with HIV in Kenya.

  Recruiting Fred Hutchinson Cancer Center · Nairobi · NCT07468695

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.